First Light Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-1,897,506
| Closed | -$15.2M | – | 79 |
|
2021
Q4 | $15.2M | Sell |
1,897,506
-725,525
| -28% | -$5.81M | 1.09% | 30 |
|
2021
Q3 | $25.5M | Sell |
2,623,031
-350,061
| -12% | -$3.41M | 1.68% | 25 |
|
2021
Q2 | $29.4M | Sell |
2,973,092
-701,012
| -19% | -$6.94M | 1.77% | 25 |
|
2021
Q1 | $42.4M | Buy |
3,674,104
+282,692
| +8% | +$3.26M | 2.81% | 15 |
|
2020
Q4 | $32.7M | Buy |
3,391,412
+1,531,387
| +82% | +$14.8M | 2.42% | 14 |
|
2020
Q3 | $16.8M | Sell |
1,860,025
-224,078
| -11% | -$2.02M | 1.72% | 20 |
|
2020
Q2 | $25.7M | Buy |
2,084,103
+240,857
| +13% | +$2.97M | 2.99% | 11 |
|
2020
Q1 | $16.6M | Buy |
1,843,246
+187,075
| +11% | +$1.68M | 2.83% | 16 |
|
2019
Q4 | $16.2M | Buy |
1,656,171
+686,941
| +71% | +$6.73M | 2.07% | 16 |
|
2019
Q3 | $6.67M | Sell |
969,230
-3,004
| -0.3% | -$20.7K | 1.01% | 29 |
|
2019
Q2 | $8.97M | Buy |
972,234
+659,351
| +211% | +$6.09M | 1.25% | 27 |
|
2019
Q1 | $4.91M | Buy |
312,883
+32,276
| +12% | +$506K | 0.64% | 39 |
|
2018
Q4 | $4.33M | Buy |
+280,607
| New | +$4.33M | 0.69% | 34 |
|